natgillin/translations-raw huggingface dataset:
S-[(6-Chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos)
Cymbopogon winterianusolje, frakcionirano, hidrirano, ciklizirano
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride
Ni na voljo
Eucalyptus citriodora oil, hydrated, cyclized
Eucalyptus citriodora olje in citronelal, hidrirano, ciklizirano
Cymbopogon winterianus oil, fractionated, hydrated, cyclized
2-hidroksi-α,α,4-trimetilcikloheksanmetanol
Not available
3-jodo-2-propinil butilkarbamat (IPBC)
Eucalyptus citriodora oil and citronellal, hydrated, cyclized
Tetrakis(hidroksimetil)fosfonijev sulfat (2:1) (THPS)
2-Hydroxy-α,α,4-trimethylcyclohexanemethanol
4,5-dikloro-2-oktilizotiazol-3(2H)-on (4,5-dikloro-2-oktil-2H-izotiazol-3-on (DCOIT))
3-Iodo-2-propynylbutylcarbamate (IPBC)
Reakcijski produkti paraformaldehida in 2-hidroksipropilamina (v razmerju 3:2) (MBO)
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)
Alkil (C12–18) dimetilbenzil amonijev klorid (ADBAC (C12–18))
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro- 2-octyl-2H- isothiazol-3-one (DCOIT))
Alkil (C12–16) dimetilbenzil amonijev klorid (ADBAC/BKC (C12–16))
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (MBO)
Didecildimetilamonijev klorid (DDAC (C8-10))
Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18))
Kvaterne amonijeve spojine, benzil-C12–18-alkildimetil, soli z 1,2-benzizotiazol-3(2H)-on 1,1-dioksidom (1:1) (ADBAS)
Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16))
Natrijev N-(hidroksimetil)glicinat
Didecyldimethylammonium chloride (DDAC (C8-10))
Amini, C10–16-alkildimetil, N-oksidi
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS)
Pentakalijev bis(peroksimonosulfat)bis(sulfat) (KPMS)
Sodium N-(hydroxymethyl)glycinate
Aktivni klor, pridobljen iz natrijevega klorida z elektrolizo
Amines, C10-16-alkyldimethyl, N-oxides
Aktivni klor, sproščen iz hipoklorove kisline
Pentapotassium bis(peroxymonosulfate)bis(sulfate) (KPMS)
Aktivni klor, pridobljen iz natrijevega klorida in pentakalijevega bis(peroksimonosulfat)bis(sulfata)
Active chlorine generated from sodium chloride by electrolysis
Aktivni klor, pridobljen iz morske vode (natrijev klorid) z elektrolizo
Active chlorine released from hypochlorous acid
Aktivni klor, pridobljen iz magnezijevega klorida heksahidrata in kalijevega klorida z elektrolizo
Active chlorine generated from sodium chloride and pentapotassium bis(peroxymonosulfate)bis(sulfate)
Aktivni klor, pridobljen iz magnezijevega klorida heksahidrata z elektrolizo
Active chlorine generated from seawater (sodium chloride) by electrolysis
Aktivni klor, pridobljen iz kalijevega klorida z elektrolizo
Active chlorine generated from magnesium chloride hexahydrate and potassium chloride by electrolysis
Aktivni klor, pridobljen iz natrijevega N- klorosulfamata
Active chlorine generated from magnesium chloride hexahydrate by electrolysis
Aktivni klor, pridobljen iz natrijevega klorida in pentakalijevega bis(peroksimonosulfat)bis(sulfata) in sulfaminske kisline
Active chlorine generated from potassium chloride by electrolysis
Aktivni klor, pridobljen iz klorovodikove kisline z elektrolizo
Active chlorine generated from sodium N- chlorosulfamate
Divodikov bis[monoperoksiftalato(2-)-O1,OO1]magnezat(2-) (MMPP)
Active chlorine generated from sodium chloride and pentapotassium bis(peroxymonosulfate)bis(sulfate) and sulfamic acid
Margoza, ekstrakt, ekstrahiran iz hladno stisnjenega olja iz jedrc Azadirachta indicas superkritičnim ogljikovim dioksidom
Active chlorine generated from hydrochloric acid by electrolysis
Alkil (C12-C14) dimetilbenzilamonijev klorid (ADBAC (C12-C14))
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) (MMPP)
Alkil (C12–C14) dimetil(etilbenzil)amonijev klorid (ADEBAC (C12–C14))
Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxide
Krizantema (Chrysanthemum cinerariaefolium), ekstrakt
Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14))
Chrysanthemum cinerariaefolium, ekstrakt, pridobljen iz odprtih in zrelih cvetov Tanacetum cinerariifolium z ogljikovodikovim topilom
Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14))
Chrysanthemum cinerariaefolium, ekstrakt, pridobljen iz odprtih in zrelih cvetov Tanacetum cinerariifolium s superkritičnim ogljikovim dioksidom
Chrysanthemum cinerariaefolium, ext.
Sivka, Lavandula hybrida, ekstrakt/olje sivke
Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvent
Reakcijski produkti: glutaminske kisline in N-(C12–14-alkil)propilendiamina (glukoprotamin)
Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide
6-(ftalimido)peroksiheksanojska kislina (PAP)
Lavender, Lavandula hybrida, ext./Lavandin oil
2-butil-benzo[d]izotiazol-3-on (BBIT)
Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)
Klorov dioksid, pridobljen iz kompleksa tetrakloro dekaoksida (TCDO) z acidifikacijo
6-(Phthalimido)peroxyhexanoic acid (PAP)
Srebrov natrijev vodikov cirkonijev fosfat
2-Butyl-benzo[d]isothiazol-3-one (BBIT)
Sek-butil 2-(2-hidroksietil)piperidin-1-karboksilat (ikaridin)
Chlorine dioxide generated from tetrachlorodecaoxide complex (TCDO) by acidification
Cis-1-(3-kloroalil)-3,5,7-triaza-1-azoniaadamantanijev klorid (cis CTAC)
Silver sodium hydrogen zirconium phosphate
Peroksioktanojska kislina
sec-Butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate (Icaridine)
Srebrov zeolit
cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC)
Reakcijski produkti 5,5-dimetilhidantoina, 5-etil-5-metilhidantoina z bromom in klorom (DCDMH)
Reaction mass of titanium dioxide and silver chloride
Srebrov cinkov zeolit
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH)
Srebrov bakrov zeolit
Silver phosphate glass
Srebro, adsorbirano na silicijevem dioksidu (kot nanomaterial v obliki stabilnega agregata s primarnimi delci v nanovelikosti)
Silver zinc zeolite
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R;1R,3S)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (zmes 4 izomerov: 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-aletrin)
Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale)
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (zmes 2 izomerov: 1R trans: 1R/S samo 1:3) (esbiotrin)
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin)
4-bromo-2-(4-klorofenil)-1-etoksimetil-5-trifluorometilpirol-3-karbonitril (klorfenapir)
Plant protection product
Polimer N-metilmetanamina (EINECS 204-697-4 s (klorometil)oksiranom (EINECS 203-439-8)/polimerni kvaterni amonijev klorid (PQ polimer)
4-Bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr)
Poliheksametilen bigvanidinijev hidroklorid s srednjo povprečno molekulsko maso (Mn) 1415 in srednjo polidisperznostjo (PDI) 4.7 (PHMB (1415: 4.7)
Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer)
32289-58-0 in 1802181-67-4
Polymer
Poli(oksi-1,2-etandiil),.alfa.-[2-(didecilmetilamonio)etil]-.omega.-hidroksi-, propanoat (sol) (Bardap 26)
Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 (PHMB(1415;4.7))
N-didecil-N-dipolietoksiamonijev borat/didecilpolioksetilamonijev borat (polimerni betain)
32289-58-0 and 1802181-67-4
Ekstraktivne snovi in njihovi fizikalno modificirani derivati.
Poly(oxy-1,2-ethanediyl),.alpha.-[2-(didecylmethylammonio)ethyl]-.omega.-hydroxy-, propanoate (salt) (Bardap 26)
To je izdelek, ki lahko vsebuje smolne kisline in njihove estre, terpene ter oksidacijske ali polimerizacijske produkte teh terpenov.
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine)
Capsicum annuum, ekstrakt.
Extractives and their physically modified derivatives.
Reakcijska zmes (6E)-N- (4-hidroksi-3-metoksi-2-metilfenil) -8-metilnon-6-enamida in N- (4-hidroksi-3-metoksi-2-metilfenil) -8-metilnonanamida
It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes.
D-fruktoza
Capsicum annuum, ext.
Med
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Capsicum annuum, Solanaceae.
Slad, ekstrakt
Reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnonanamide
Ekstrakti in njihovi fizično spremenjeni derivati, kot so tinkture, zgoščena olja, čista olja, eterična olja, oljne smole, terpeni, frakcije brez terpena, destilati, ostanki itd., pridobljeni iz Hordeum, Gramineae.
D-Fructose
Kis
Honey
(kategorija živil, ki vsebuje največ 10 % ocetne kisline)
Malt, ext.
Sir
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hordeum, Gramineae.
Jajca v prahu
Vinegar
Zgoščen jabolčni sok
(food grade containing a maximum of 10 % acetic acid)
Pomarančevec, sladki, ekstrakt
Cheese
Ekstrakti in njihovi fizično spremenjeni derivati, kot so tinkture, zgoščena olja, čista olja, eterična olja, oljne smole, terpeni, frakcije brez terpena, destilati, ostanki itd., pridobljeni iz Citrus sinensis, Rutaceae.
Powdered egg
Česen, ekstrakt
Concentrated apple juice
Ekstrakti in njihovi fizično spremenjeni derivati, kot so tinkture, zgoščena olja, čista olja, eterična olja, oljne smole, terpeni, frakcije brez terpena, destilati, ostanki itd., pridobljeni iz Allium sativum, Liliaceae.
Commission Implementing Regulation (EU) 2019/158
Izvedbena uredba Komisije (EU) 2019/158
renewing the approval of the active substance methoxyfenozide, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o obnovitvi odobritve aktivne snovi metoksifenozid kot kandidatke za zamenjavo v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
Commission Directive 2005/3/EC included methoxyfenozide as an active substance in Annex I to Council Directive 91/414/EEC.
Direktiva Komisije 2005/3/ES je vključila metoksifenozid kot aktivno snov v Prilogo I k Direktivi Sveta 91/414/EGS.
The approval of the active substance methoxyfenozide, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011 expires on 31 July 2019.
Odobritev aktivne snovi metoksifenozid, kot je določena v delu A Priloge k Izvedbeni uredbi (EU) št. 540/2011, preneha veljati 31. julija 2019.
An application for the renewal of the approval of methoxyfenozide was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 within the time period provided for in that Article.
Zahtevek za obnovitev odobritve metoksifenozida je bil predložen v skladu s členom 1 Izvedbene uredbe Komisije (EU) št. 844/2012 v roku, določenem v navedenem členu.
The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 4 August 2016.
Država članica poročevalka je pripravila poročilo o oceni obnovitve v posvetovanju z državo članico soporočevalko ter ga 4. avgusta 2016 predložila Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
On 10 August 2017 the Authority communicated to the Commission its conclusions on whether methoxyfenozide can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Agencija je Komisiji 10. avgusta 2017 predložila svoje sklepe o tem, ali se za metoksifenozid lahko pričakuje, da bo izpolnjeval merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The Commission presented the draft renewal report for methoxyfenozide to the Standing Committee on Plants, Animals, Food and Feed on 25 May 2018.
Komisija je osnutek poročila o obnovitvi metoksifenozida 25. maja 2018 predložila Stalnemu odboru za rastline, živali, hrano in krmo.
As regards the new criteria to identify endocrine disrupting properties introduced by Commission Regulation (EU) 2018/605, which became applicable on 10 November 2018, the conclusion of the Authority infers that it is highly unlikely that methoxyfenozide is an endocrine disrupter via the estrogenic, androgenic and steroidogenic modalities.
Kar zadeva nova merila za opredelitev lastnosti endokrinih motilcev, uvedenih z Uredbo Komisije (EU) 2018/605, ki je začela veljati 10. novembra 2018, je v sklepu Agencije zaključeno, da je malo verjetno, da bi metoksifenozid lahko povzročil endokrine motnje pri sintezi estrogenov, androgenov in steroidov.
Furthermore, the available evidence (amphibian metamorphosis assay) indicates that methoxyfenozide is unlikely to be an endocrine disruptor via the thyroid modality.
Polega tega razpoložljivi dokazi (preskus preobrazbe dvoživk) kaže, da je malo verjetno, da bi metoksifenozid lahko povzročil endokrine motnje pri ščitničnem delovanju.
Thus, the Commission considers that methoxyfenozide is not to be considered as having endocrine disrupting properties.
Zato Komisija meni, da ni mogoče šteti, da ima metoksifenozid lastnosti, ki lahko povzročajo motnje endokrinega sistema.
It has been established with respect to one or more representative uses of at least one plant protection product containing methoxyfenozide that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
V zvezi z eno ali več reprezentativnimi uporabami vsaj enega fitofarmacevtskega sredstva, ki vsebuje metoksifenozid, je bilo ugotovljeno, da so merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 izpolnjena.
It is therefore appropriate to renew the approval of methoxyfenozide.
Zato je primerno obnoviti odobritev metoksifenozida.
The risk assessment for the renewal of the approval of methoxyfenozide is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing methoxyfenozide may be authorised.
Ocena tveganja za obnovitev odobritve metoksifenozida temelji na omejenem številu reprezentativnih uporab, ki pa ne omejujejo uporab, za katere se lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo metoksifenozid.
It is therefore appropriate to remove the restriction for use only as an insecticide.
Zato je primerno, da se omejitev na uporabo navedene snovi samo kot insekticida odpravi.
The Commission, however, considers that methoxyfenozide is a candidate for substitution pursuant to Article 24 of Regulation (EC) No 1107/2009.
Vendar Komisija meni, da je aktivna snov metoksifenozid kandidatka za zamenjavo v skladu s členom 24 Uredbe (ES) št. 1107/2009.
Methoxyfenozide is a persistent and toxic substance in accordance with points 3.7.2.1 and 3.7.2.3 respectively, of Annex II to Regulation (EC) No 1107/2009, given that the half-life in soil and water is greater than 120 days and the long-term no-observed effect concentration for freshwater organisms is less than 0,01 mg/L.
Metoksifenozid je obstojna in toksična snov v skladu s točkama 3.7.2.1 in 3.7.2.3 Priloge II k Uredbi (ES) št. 1107/2009, glede na to, da je razpolovna doba v tleh in vodi daljša od 120 dni in da je dolgoročna koncentracija neopaženih učinkov pri sladkovodnih organizmih manjša od 0,01 mg/l.
Methoxyfenozide therefore fulfils the condition set in the second indent of point 4 of Annex II to Regulation (EC) No 1107/2009.
Metoksifenozid zato izpolnjuje pogoje iz točke 4 Priloge II k Uredbi (ES) št. 1107/2009.
It is therefore appropriate to renew the approval of methoxyfenozide as a candidate for substitution pursuant to Article 24 of Regulation (EC) No 1107/2009.
Zato je primerno obnoviti odobritev aktivne snovi metoksifenozid kot kandidatke za zamenjavo v skladu s členom 24 Uredbe (ES) št. 1107/2009.
It is, in particular, appropriate to restrict the use of plant protection products containing methoxyfenozide to greenhouses in order to minimise the exposure for groundwater and non-target organisms and to require further confirmatory information.
Zlasti je primerno omejiti uporabo fitofarmacevtskih sredstev, ki vsebujejo metoksifenozid, na rastlinjake, da se zmanjša izpostavljenost podzemne vode in neciljnih organizmov, ter zahtevati nadaljnje potrditvene informacije.
Although it can be reasonably expected that metoxyfenozide is highly unlikely to have endocrine disrupting properties based on the available scientific information summarised in the conclusion of the Authority, in order to increase the confidence in this conclusion, in accordance with Point 2(2)(b) of Annex II to Regulation (EC) No 1107/2009, the applicant should provide an updated assessment of the information submitted and, where relevant, further information to confirm the absence of thyroid endocrine activity.
Čeprav je mogoče na osnovi razpoložljivih znanstvenih informacij, povzetih v sklepu Agencije, pričakovati, da metoksifenozid zelo verjetno nima lastnosti endokrinih motilcev, bi za povečanje zaupanja v ta sklep, v skladu s točko 2(2)(b) Priloge II k Uredbi (ES) št. 1107/2009, moral vlagatelj zagotoviti posodobljeno oceno predloženih informacij in po potrebi dodatne informacije za potrditev odsotnosti motnje endokrinega delovanja ščitnice.
Commission Implementing Regulation (EU) 2018/917 extended the approval period of methoxyfenozide to 31 July 2019 in order to allow the renewal process to be completed before the expiry of the approval of that substance.
Z Izvedbeno uredbo Komisije (EU) 2018/917 je bilo podaljšano obdobje odobritve metoksifenozida do 31. julija 2019, da bi se omogočil zaključek postopka obnovitve pred prenehanjem njegove odobritve.
However, given that a decision on renewal has been taken ahead of this extended expiry date, this Regulation should apply from 1 April 2019.
Vendar ker je bil sklep o obnovitvi sprejet pred podaljšanim datumom prenehanja odobritve, bi se ta uredba morala uporabljati od 1. aprila 2019.
The approval of the active substance methoxyfenozide, as a candidate for substitution, is renewed as set out in Annex I.
Odobritev aktivne snovi metoksifenozid kot kandidatke za zamenjavo se obnovi, kot je določeno v Prilogi I.
Commission Directive 2005/3/EC of 19 January 2005 amending Council Directive 91/414/EEC to include imazosulfuron, laminarin, methoxyfenozide and s-metolachlor as active substances (OJ L 20, 22.1.2005, p. 19).
Direktiva Komisije 2005/3/ES z dne 19. januarja 2005 o spremembi Direktive Sveta 91/414/EGS zaradi vključitve imazosulfurona, laminarina, metoksifenozida in s-metolaklora na seznam aktivnih snovi (UL L 20, 22.1.2005, str. 19).
Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties (OJ L 101, 20.4.2018, p. 33).
Izvedbena uredba Komisije (EU) 2018/917 z dne 27. junija 2018 o spremembi Izvedbene Uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi alfa-cipermetrin, beflubutamid, benalaksil, bentiavalikarb, bifenazat, boskalid, bromoksinil, kaptan, karvon, klorprofam, ciazofamid, desmedifam, dimetoat, dimetomorf, dikvat, etefon, etoprofos, etoksazol, famoksadon, fenamidon, fenamifos, flumioksazin, fluoksastrobin, folpet, foramsulfuron, formetanat, Gliocladium catenulatum sev: J1446, izoksaflutol, metalaksil-m, metiokarb, metoksifenozid, metribuzin, milbemektin, oksasulfuron, Paecilomyces lilacinus sev 251, fenmedifam, fosmet, pirimifos-metil, propamokarb, protiokonazol, pimetrozin in S-metolaklor (UL L 163, 28.6.2018, str. 13).
Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor (OJ L 163, 28.6.2018, p. 13).
PRILOGA I
Specific provisions
metoksifenozid
Methoxyfenozide
št.
CAS No 161050-58-4
CAS 161050-58-4
CIPAC No 656
št.
N-tert-Butyl-N′-(3-methoxy-o-toluoyl)-3,5-xylohydrazide
CIPAC 656
The following impurities must not exceed the following levels in the technical material:
N-terc-butil-N′-(3-metoksi-o-toluoil)-3,5-ksilohidrazid
Tert-butylhydrazine < 0,001 g/kg
Naslednje nečistoče ne smejo presegati določene količine tehničnega materiala:
RH-116267 < 2 g/kg
terc-butil hidrazin < 0,001 g/kg
1 April 2019
RH-116267 < 2 g/kg
31 March 2026
1. april 2019
Only uses in greenhouses shall be authorised.
31. marec 2026
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on methoxyfenozide, and in particular Appendices I and II thereto, shall be taken into account.
Registrira se le za uporabe v rastlinjakih.
In their overall assessment Member States shall pay particular attention to:
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu metoksifenozida ter zlasti dodatka I in II k poročilu.
the protection of groundwater when the substance is applied in regions with vulnerable soil and/or climate conditions;
V svoji celoviti oceni morajo biti države članice zlasti pozorne na:
the risk of accumulation in soil;
zaščito podzemne vode, kadar se snov uporablja na območjih z občutljivimi tlemi in/ali neugodnimi podnebnimi razmerami;
the protection of non-target arthropods, sediment dwelling and aquatic organisms;
tveganje akumulacije v tleh;
Conditions of use shall include risk mitigation measures, where appropriate.
zaščito neciljnih členonožcev, organizmov, ki živijo v usedlinah, in vodnih organizmov;
The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:
Pogoji uporabe po potrebi vključujejo ukrepe za zmanjšanje tveganja.
a comparative in vitro metabolism study on methoxyfenozide, by 1 April 2020;
Vlagatelj predloži Komisiji, državam članicam in Agenciji potrditvene informacije glede:
the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or groundwater is abstracted for drinking water, within 2 years after adoption of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.
primerjalne študije o presnovi metoksifenozida in vitro do 1. aprila 2020;